Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Viet Nam

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 5, 2001, Pages 513-517

  Thanh, N V ^a   Cowman, A F ^b   Hipgrave, D ^c,d   Kim, T B ^a   Phuc, B Q ^a   Cong, L D ^a   Biggs, B A ^d,e  

^a National Institute of Malariology Parasitology and Entomology Hanoi   (Viet Nam)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c Vietnam Ministry of Health   (Viet Nam)

^d Macfarlane Burnet Ctr Med Research   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Artemisinin; Chloroquine; Drug sensitivity; In vitro; Malaria; Mefloquine; Plasmodium falciparum; Quinine; Sulfadoxine pyrimethamine; Trends; Viet Nam

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISIN; CHLOROQUINE; FANSIDAR; MEFLOQUINE; QUININE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CONTROLLED STUDY; DRUG USE; HUMAN; IN VITRO STUDY; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALARIA; NONHUMAN; PARASITE ISOLATION; PATIENT MONITORING; PLASMODIUM FALCIPARUM; RECURRENT DISEASE; TREATMENT OUTCOME; VIET NAM;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG RESISTANCE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MEFLOQUINE; MICROBIAL SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; QUININE; SESQUITERPENES; SULFADOXINE;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0035467592     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90023-9     Document Type: Article

References (20)

1. National Malaria Treatment Guidelines
2. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives
3. Chloroquine-resistant falciparum malaria acquired in Vietnam
4. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam
5. Management of multiple drug-resistant malaria in Vietnam
6. Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum
7. Mechanisms and dynamics of drug resistance in Plasmodium falciparum
8. A simplified method for evaluating dose-effect
9. Malaria in Vietnam in 1996: Brief synthesis of epidemiological data
10. Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon
11. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs
12. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea
13. Drug sensitivity to Plasmodium falciparum. An in-vitro microtechnique
14. Sulfadoxine and pyrimethamine in the treatment of falciparum malaria in Vietnam
15. The clinical efficacy of and tolerance for Lariam (mefloquine) in tropical malaria in the south of the Socialist Republic of Vietnam
16. The valuation of in vitro test for the assessment of drug response in Plasmodium falciparum
17. In vitro micro-test (Mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, sulfadoxine/pyrimethamine and amodiaquine
18. In vitro micro-test (Mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, meflouine, quinine, sulfadoxine/pyrimethamine and artemisinin
19. In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials
20. Plasmodium falciparum: Mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation and coexistence of two clones in a Thai patient